Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 77.82B | 75.93B | 74.88B | 71.98B | 62.27B | 55.25B |
Gross Profit | 30.43B | 29.82B | 29.12B | 25.85B | 22.74B | 19.89B |
EBITDA | 16.15B | 16.17B | 16.04B | 11.40B | 11.21B | 9.41B |
Net Income | 9.84B | 8.30B | 7.95B | 3.72B | 6.16B | 4.03B |
Balance Sheet | ||||||
Total Assets | 162.59B | 147.81B | 145.07B | 151.50B | 139.61B | 123.90B |
Cash, Cash Equivalents and Short-Term Investments | 23.93B | 11.46B | 11.13B | 12.99B | 12.05B | 16.72B |
Total Debt | 57.52B | 47.92B | 46.60B | 50.64B | 48.70B | 44.57B |
Total Liabilities | 99.42B | 91.58B | 92.01B | 96.70B | 90.33B | 84.07B |
Stockholders Equity | 57.57B | 51.26B | 47.79B | 48.90B | 44.37B | 36.39B |
Cash Flow | ||||||
Free Cash Flow | 9.75B | 9.58B | 10.02B | 8.16B | 8.27B | 7.31B |
Operating Cash Flow | 12.01B | 11.66B | 12.24B | 10.24B | 10.00B | 8.86B |
Investing Cash Flow | -5.97B | -3.28B | -3.18B | -2.49B | -15.49B | -5.18B |
Financing Cash Flow | -1.05B | -8.88B | -8.73B | -7.50B | 785.00M | 3.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $149.20B | 38.49 | 20.84% | 1.04% | 7.00% | 16.84% | |
78 Outperform | $193.02B | 18.45 | 15.04% | 2.30% | -1.01% | 31.83% | |
77 Outperform | $90.99B | 27.41 | 27.16% | 0.94% | -0.23% | 22.41% | |
73 Outperform | $73.93B | 22.14 | 109.06% | 2.38% | -1.40% | 11.65% | |
69 Neutral | $79.75B | 33.84 | 9.82% | 1.49% | 6.49% | 24.14% | |
69 Neutral | $38.83B | 43.37 | 25.86% | 1.50% | -11.19% | -22.50% | |
64 Neutral | $10.61B | 16.56 | 6.55% | 2.15% | 2.87% | -30.79% |